Abstract The mammalian homeostatic oxygen sensing system (HOSS) initiates changes in vascular tone, respiration, and neurosecretion that optimize oxygen uptake and tissue oxygen delivery within seconds of detecting altered environmental or arterial PO 2 . The HOSS includes carotid body type 1 cells, adrenomedullary cells, neuroepithelial bodies, and smooth muscle cells (SMCs) in pulmonary arteries (PAs), ductus arteriosus (DA), and fetoplacental arteries. Hypoxic pulmonary vasoconstriction (HPV) optimizes ventilation-perfusion matching. In utero, HPV diverts placentally oxygenated blood from the non-ventilated lung through the DA. At birth, increased alveolar and arterial oxygen tension dilates the pulmonary vasculature and constricts the DA, respectively, thereby transitioning the newborn to an air-breathing organism. Though modulated by endothelial-derived relaxing and constricting factors, O 2 sensing is intrinsic to PASMCs and DASMCs. Within the SMC's dynamic mitochondrial network, changes in PO 2 alter the reduction-oxidation state of redox couples (NAD + /NADH, NADP + /NADPH) and the production of reactive oxygen species, ROS (e.g., H 2 O 2 ), by complexes I and III of the electron transport chain (ETC). ROS and redox couples regulate ion channels, transporters, and enzymes, changing intracellular calcium [Ca 2+ ] i and calcium sensitivity and eliciting homeostatic responses to hypoxia. In PASMCs, hypoxia inhibits ROS production and reduces redox couples, thereby inhibiting O 2 -sensitive voltage-gated potassium (Kv) channels, depolarizing the plasma membrane, activating voltage-gated calcium channels (Ca L ), increasing [Ca 2+ ] i , and causing vasoconstriction. In DASMCs, elevated PO 2 causes mitochondrial fission, increasing ETC complex I activity and ROS production. The DASMC's downstream response to elevated PO 2 (Kv channel inhibition, Ca L activation, increased [Ca 2+ ] i , and rho kinase activation) is similar to the PASMC's hypoxic response. Impaired O 2 sensing contributes to human diseases, including pulmonary arterial hypertension and patent DA.
Introduction
Although human life requires oxygen, all humans begin life in the hypoxic intrauterine environment. The fetus receives oxygen from the mother through the placenta. With the first breath, at the moment of birth, we are exposed to elevated oxygen concentrations in the environment. Thereafter, we live in an environment in which oxygen is usually abundant. However, as we proceed through life, we may be exposed to hypoxia both as a consequence of changes in our environment, such as exposure to high altitude, or through disease (e.g., pneumonia and atelectasis). In the modern era of artificial ventilation, we may also experience hyperoxia.
Oxygen is required for mammalian life because mammals have high energy demand. Oxygen's ability to receive electrons permits it to participate in an elegant cascade within the mitochondria that ultimately produces energy-rich phosphates (ATP). Situated at the distal end of a redox cascade (the mitochondrial electron transport chain, ETC), oxygen receives electrons and, in doing so, is reduced, forming water. The reductive journey of electrons down a redox gradient begins with electron donors nicotinamide adenine dinucleotide (NADH) and flavin adenine dinucleotide (FADH 2 ), which are produced by mitochondrial metabolic cycles, notably, the Krebs cycle. These donors pass their electrons down a redox potential gradient that is spread over four mega-complexes (ETC complexes I-IV) spanning the inner mitochondrial membrane. This electron transport powers the pumping of hydrogen ions across the inner mitochondrial membrane and, in so doing, generates the potential energy to power ATP synthesis.
The range of physiologically optimal oxygen tension is narrow; too much or too little oxygen can result in disease. Evolution has endowed mammals with a network of specialized tissues that sense oxygen in their local environment. These tissues couple an upstream mitochondrial O 2 sensor mechanism with downstream redox-responsive effectors (ion channels and enzymes). Upon sensing small changes in PO 2 , these effectors initiate compensatory responses that optimize the uptake and delivery of oxygen to our tissues. This network is called the homeostatic oxygen sensing system (HOSS) [96] . The components of the HOSS are strategically distributed in the body to rapidly optimize oxygen uptake and distribution in response to small changes in airway oxygen levels (FiO 2 ) or blood oxygen levels (PO 2 ).
The HOSS includes type 1 cells in the carotid body, and smooth muscle cells (SMCs) in small pulmonary arteries (PAs), fetoplacental arteries in the placenta, and the ductus arteriosus (DA). HOSS components can increase ventilation to enhance oxygen uptake (the type 1 cells in the carotid body), match ventilation to perfusion in the lung to avoid perfusing hypoxic lung segments (PASMCs in small resistance-level pulmonary arteries), and redistribute blood to hypoxic organs by causing vasodilatation (SMCs in the DA or systemic arteries). Additional components of this homeostatic system include the adrenomedullary chromaffin cells in the adrenal glands, which can release catecholamines to counteract hypoxic stress at birth, and neuroepithelial bodies, neuroendocrine cells in the airways, the function of which is less well understood. The HOSS should arguably be considered one of the body's major physiologic systems, on equal footing with the cardiovascular, nervous, or endocrine systems.
Attributes of HPV
Since its first description 120 years ago by Bradford and Dean [16] , and subsequent more extensive description by von Euler and Liljestrand [24] , the search for the mechanism of hypoxic pulmonary vasoconstriction (HPV) has been the subject of much research [4, 10, 64, 66-68, 93, 95-97] . The field has also seen substantial debate [88, 94] . To help clarify the study of HPV, it is essential to understand its physiologic phenotype. The basic attributes of HPV include its rapid onset. HPV onsets within seconds of exposure to hypoxia [42] and reaches a maximum within minutes [13] . HPV is also completely reversible upon restoration of normoxia [82] . In addition, HPV is primarily elicited by alveolar hypoxia, rather than pulmonary arterial hypoxemia. Consistent with this responsiveness to alveolar hypoxia, HPV is strongest in the resistance pulmonary arteries (PAs), which are exposed to alveolar oxygen tensions (FiO 2 ). The fact that HPV is reversible and localized to the region of the lung that is hypoxic is illustrated in Fig. 1 . In this patient, airway hypoxia caused by a mucus plug in the left lung's main bronchus led to corresponding left lung HPV, thereby reducing left lung perfusion and optimizing systemic PO 2 . HPV was sustained until the mucous plug was removed by means of bronchoscopic aspiration.
Hypoxic constriction is unique to the PAs; systemic arteries, such as the mesenteric arteries [101] and renal arteries [61] , relax in response to hypoxia. Likewise, at the cellular level, PASMCs from PAs constrict to hypoxia while cerebral artery SMCs relax [51] . There is a longitudinal heterogeneity in the magnitude of HPV in cats, with HPV being greater in small, resistance PAs (diameter <300 μm) and less in large, conduit PAs (diameter >500 μm). Indeed, larger PAs behave like systemic arteries, exhibiting neither significant hypoxic constriction nor hypoxic PASMC depolarization [50] . Similar localization of HPV to resistance PAs is noted in the rat [6, 12] . On a molecular level, the downstream constrictor mechanism in HPV is well accepted to result, in large part, from a rise in intracellular calcium in PASMCs [58] .
Role of potassium and calcium channels in HPV
The effector mechanism of HPV involves the coordinated activity of redox-and voltage-sensitive K + [74] and Ca 2+ channels [93] . McMurtry et al. showed that verapamil, an inhibitor of large-conductance, voltage-gated calcium channels (Ca L ), virtually eliminated HPV in an isolated perfused rat lung. This indicates that the calcium required for HPV is largely derived from the extracellular pool and enters the PAs via Ca L channels [58] , a finding reinforced by Harder in studies conducted in isolated PA rings [35] . Conversely, HPV is enhanced by Ca L channel agonists, such as BAY K8644 [57, 86] . The sensitivity of Ca L channels to changes in oxygen tension varies longitudinally along the pulmonary vasculature. Resistance PAs have increased Ca L channel current density and greater I Ca hypoxia sensitivity, as compared to conduit PAs [27] .
Ca L channels are voltage-dependent and cell membrane depolarization favors their activation (although the Ca L can be intrinsically O 2 -sensitive [27] ). Potassium (K + ) channels are known to regulate membrane potential (E m ) in multiple cell types, including SMCs. In pharmacology experiments using isolated perfused rodent lungs, Hasunuma et al. showed that the K + channel blockers, tetraethylammonium (TEA) and 4-aminopyridine (4-AP), cause pulmonary vasoconstriction [36] . Post et al. used the whole-cell patch clamp technique to directly demonstrate that outward potassium current (I K ) creates the PASMC's relatively negative E m (less than −50 mV). This electronegativity prevents opening of the Ca L channels, which have their own voltage sensor that favors channel opening at more positive, depolarized, membrane potentials (i.e., > −20 mV) [74] . The PASMC's I K is inhibited by hypoxia, leading to membrane depolarization and vasoconstriction. Post also demonstrated that K + channel antagonists, notably the voltage-gated K + channel (Kv) inhibitor 4-AP, mimicked the hypoxic response in isolated rat lung as well as PA rings, increasing pulmonary artery pressure (PAP). 4-AP inhibits the hypoxia-sensitive portion of I K in isolated rat PASMCs [74] . Although blockers of the Ca L eliminate the majority of HPV [35, 58] , hypoxia also increases intracellular calcium by enhancing release from the sarcoplasmic reticulum (SR) [79] . Hypoxia can also directly enhance calcium entry through the Ca L [28] .
Initially, pharmacology and electrophysiology were used to suggest the identity of the oxygen-sensitive K + channels involved in HPV. These studies showed that the PASMC's hypoxia-sensitive I K current was sensitive to 4-AP, but not TEA or charybdotoxin (CTX), inhibitors of large conductance, Ca 2+ -sensitive K + channels (BK Ca ). The hypoxiasensitive I K was predominant in PASMCs isolated from resistance PAs, whereas a BK Ca -predominant I K was evident in PASMCs derived from conduit PAs (which dilate in response to hypoxia) [6] . Subsequently, correolide, an inhibitor of Kv1.x channels, provided further specificity showing that much of the hypoxia-sensitive I K in PASMCs was conducted by member of the Kv1.x channel family. Molecular studies ultimately identified specific voltagegated, O 2 -sensitive K + channels that elicit HPV, including Kv1.5 and Kv2.1 [12] . Kv1.5 mRNA and protein levels are increased in resistance PAs (relative to conduit PAs), and the majority of I K in these arteries is inhibited by correolide. Inhibition of Kv1.5 and Kv2.1, achieved by administering antibodies against these channels to the intracellular space using a patch pipette, results in additive inhibition of cell depolarization. Superimposition of hypoxia after addition of the anti-Kv antibodies does not result in further membrane depolarization. This suggests that these two channels contribute a majority of the hypoxia-sensitive I K . Consistent with this, Platoshyn et al. demonstrated that expression of Kv1.5 is proportional to sensitivity to hypoxia and that heterogeneity in the expression of Kv1.5 channels among PA segments accounts in part for regional heterogeneity in the magnitude of HPV [73] . Finally, HPV is impaired in mice lacking Kv1.5, even though expression of other putative oxygen-sensitive Kv channels (Kv 1.1, 1.2, 2.1, 3.1, and 4.3) is unaltered [7] .
It is noteworthy that ion channels may be Bredox-sensitived ue to their intrinsic amino acid sequence (i.e., the presence of redox-sensitive sulfhydryl groups) [21] . Certain amino acids, such as histidine, cysteine, methionine, and tryptophan, are particularly sensitive to modification by reactive oxygen species (ROS). Thus, ROS may cause redox changes in key amino acids, thereby altering channel conformation and function. In addition, Kv channels are tetramers of α-subunits and may assemble as heterotetramers, often with associated β-subunits. The heterotetrameric composition of a channel or its association with β-subunits may alter its O 2 sensitivity. For example, when expressed in PASMCs, heterotetrameric channels comprised of Kv1.5 plus Kv1.2 or Kv2.1 plus Kv9.3 α-subunits display enhanced oxygen sensitivity compared to similar expression of homomeric channels [41] .
Another line of evidence for the role of O 2 -sensitive K + channels in the mechanism of HPV comes from studies of rats exposed to chronic hypoxia. Chronic hypoxia attenuates acute HPV while leaving other forms of vasoconstriction unaltered or enhanced [59] , and ultimately causes a form of pulmonary hypertension that is associated with decreases in the expression of both Kv1.5 and Kv2.1 [76, 102] . This loss of acute HPV in chronic hypoxic pulmonary hypertension can be reversed by infection of the lung with Kv1.5, delivered by a serotype 5 adenovirus. Kv1.5 gene therapy also reduces pulmonary hypertension and regresses both right ventricular and PA hypertrophy [75] .
Other voltage-gated channels, including Kv3.1b, have been implicated in the mechanism of HPV. Osipenko et al. used patch clamp techniques to investigate the effect of hypoxia on Kv3.1b. They reported that hypoxia inhibited Kv3.1b, but not Kv1.x channels, and that addition of TEA inhibited the electrophysiological effects of hypoxia in PASMCs [69] a finding discordant to observations reported by both Hasunuma [36] , Post [74] , and Archer [7] .
Some debate exists surrounding the role of Kv channels versus other types of K + channels in HPV. This debate revolves around consideration of the PASMC's resting E m . Two-pore K + channels (K 2P channels) have greater openstate probability at more negative E m than do Kv channels. Unlike Kv channels, they do not show desensitization with prolonged or repeated depolarization. Thus, it has been argued that they may be more relevant to HPV since they would be expected to be active at the PASMC's resting E m . However, it should be noted that, under proper experimental conditions (i.e., studying PASMCs at physiological temperature and PO 2 ) using a patch clamp protocol that does not include prolonged exposure of the cell to depolarization or extreme depolarization steps, Kv channels are also active at resting E m . Candidate K 2P channels include TWIK-related, acid-sensitive K + (TASK) channels. TASK channels conduct a background current that is voltage-independent [22] . Additional two-pore K + channels, including TASK-2, tandem pore domain halothane-inhibited K + channel 1 (THIK-1), TWIK-related K + channel 2 (TREK-2), and tandem pore domain weak inward rectifier K + channel 2 (TWIK-2), have been detected in the PASMCs [29] . However, when evaluating the potential role of K + channels in HPV, one would expect observations to be concordant with established attributes of HPV. While it is expected that inhibition of a putative candidate channel should elicit vasoconstriction (mimicking hypoxia), blockade of K 2P channels, with anandamide or bupivacaine, did not significantly increase pulmonary vascular tone [29] .
Although there is no clear explanation for these divergent findings, the majority of research surrounding TASK channels occurred using proximal rather than resistance PAs [32] . Moreover, one can envision heterogeneity in the channels involved in HPV among individuals and between species. In addition, each channel activates and inactivates at specific voltages, and therefore, there may be a rolling progression of channels inhibited by hypoxia. Those channels active at resting membrane potential would be first to be inhibited by hypoxia, but the resulting depolarization would bring into play other channels that function at more positive potentials. Other factors that result in heterogeneous reports include the failure to define PO 2 and pH in many studies. Anoxia and hypoxia are distinct, and it is important to be precise when defining study conditions and ensure they replicate conditions relevant to HPV. Finally, there is diversity in the quality of the cell used when examining the mechanism of HPV. Some laboratories use conduit PAs (which are easier to harvest but lack HPV), while others use PASMCs that have been passaged in culture. Cell culture downregulates the expression of many Kv channels and attenuates hypoxia-sensitive I K . The healthier the PASMC preparation, the more negative the resting membrane potential (usually approximately −60 mV). In evaluating the quality of the evidence for a channel's role in HPV, one should consider whether the cells being used are primary isolates from resistance PAs, whether they manifest a robust response to hypoxia, whether they have a demonstrable hypoxic response (cellular constriction or a rise in [Ca 2+ ] i ), and whether the studies were performed at optimal temperature and pH.
The downstream portion of the HPV mechanism is shared with other tissues in HOSS, albeit the specific ion channels involved and the consequence of channel inhibition vary among tissues. For example, hypoxic inhibition of I K and depolarization of the plasma membrane activates Ca L channels leading to calcium influx in the type 1 cell of the carotid body [47, 72] , the adrenomedullary cells [65] , and the neuroepithelial body [99] . However, in each of these tissues, the rise in calcium triggers secretion of mediators, rather than vasoconstriction. In the DASMCs, the downstream electrical cascade is similar to that in the PASMCs but is triggered by increased PO 2 [87] .
Mitochondria-the O 2 sensor mediating HPV
While the identity of HPV's effector mechanism is reasonably well established, the sensor and mediator components of the O 2 -sensing system are the subject of ongoing investigation (and some controversy [88, 94] ). Although there is certainly controversy, our worthy opponents in a debate on the mechanisms of HPV noted:
BCurrently, the best documented hypothesis for HPV proposes that Ca 2+ entry is mediated primarily via voltage-dependent L-type channels, as a result of hypoxia-induced inhibition of voltage-gated K + channels (Kv channels) and consequent depolarization. According to this scheme, Kv channel inhibition is caused by a decrease in the ambient intracellular concentration of H 2 O 2 which results when mitochondrial electron transport, and consequently the production of superoxide ion, falls due to the lack of O 2 . There is an enormous body of evidence supporting this hypothesis, which has been presented in a number of authoritative reviews [ 1] .
Although the O 2 -sensitive ion channels respond to changes in PO 2 , they are not themselves sensors. In fact, systemic and pulmonary arteries have a similar complement of K + and Ca 2+ channels and respond similarly to Kv channel blockers such as 4-AP with vasoconstriction, and to Ca L inhibitors, such as verapamil and nifedipine, with vasodilation. Rather, it is the vascular oxygen sensor and the sensor's susceptibility to initiate PO 2 -dependent changes in production of redox mediators that differ between these vascular beds. Mitochondria are leading candidates for the role of PA O 2 sensors. Although mitochondria rely on molecular oxygen to produce ATP, the PASMC's oxygen sensor does not rely on ATP depletion, which would be a late and extreme signal of hypoxia. Instead, the sensor monitors mitochondrial electron transport and the related production of ROS and changes in redox couples, which are perturbed by hypoxia before ATP is depleted. Recent advances in live cell imaging using mitochondrial-targeted fluorophores reveal that the PASMC's mitochondria are arrayed in an extensive network [15, 52] (Fig. 2) . Recognition of the structure and mobility of mitochondria offers biologic plausibility that these organelles are positioned to rapidly convey redox signals to ion channels in the plasma membrane as well as cytosolic enzymes within vascular SMC [63] .
Rounds and McMurtry demonstrated that various ETC inhibitors increased pulmonary vascular resistance, mimicking the effects of hypoxia in a crystalloid-perfused isolated rat lung model [80] . They postulated that the constrictor effect is related to energy depletion. However, further investigation showed that within the rapid time frame of the vasoconstriction, there was no energy depletion or change in PO 2 . Rather, these ETC inhibitors were changing cytosolic redox chemistry and mitochondrial ROS production. Moreover, while rotenone and antimycin A (specific inhibitors of complex I and complex III, respectively) recapitulated the effects of hypoxia, cyanide, an inhibitor of complex IV, did not [61] . These observations are consistent with the Redox Theory of HPV, which has gradually been refined since its initial publication in 1986 [11] , reviewed in [94, 95] . The Redox Theory (Fig. 3) postulates that the mitochondrial ETC is an important oxygen sensor that varies production of ROS in direct proportion to physiologic changes in PO 2 [64] . This is plausible, since a small percentage of electron transport involves unpaired electrons that yield superoxide anion. Superoxide anion is rapidly converted by mitochondrial superoxide dismutase 2 to H 2 O 2 , a less toxic redox mediator with a wider diffusion radius. Thus, the more electron flux, the more uncoupled electrons and ROS production [9] . Conversely, reduced electron flux results in fewer radicals and less H 2 O 2 production. This applies not only to the PAs and ductus but also to the heart (where ischemia-reperfusion is well established to reduce and increase ROS production, respectively) [38] . Evidence for diffusible mitochondrial-derived ROS being the mediator of HPV has been demonstrated through many experimental strategies. First, there are concordant effects of hypoxia and inhibitors of the proximal ETC on the pulmonary versus systemic vasculature ( scavenger) or dimethylthiourea (DMTU, a hydroxyl radical scavenger) [70] . These experiments have also been conducted using isolated, saline-perfused rat lungs. In this preparation, hypoxia also decreases the chemiluminescent signal. This decrease in ROS production (whether measured with luminol or lucigenin) precedes the increase in PAP, as would be expected if it were the signal connecting the sensor to the downstream effectors [8] (Fig. 4) . Likewise, proximal ETC inhibitors (antimycin A and rotenone) also cause pulmonary vasoconstriction and decrease ROS formation in isolated perfused rat lungs [5] . In addition, PAs from rats exposed to chronic hypoxia not only have reduced HPV but also display a concordant decrease in constriction to ETC inhibitors (whereas their constrictor responses to phenylephrine are enhanced). This selective impairment of oxygen sensing in response to chronic hypoxia is recapitulated in the fawn hooded rat, a model of spontaneous pulmonary arterial hypertension (PAH) in which there is mitochondrial fragmentation and decreased expression of ETC complex I [15] (Fig. 5 ). H 2 O 2 is known to be a pulmonary vasodilator, as demonstrated by Wolin and Burke. However, in bovine pulmonary arteries, at least some of this vasodilatation relates to activation of guanylate cyclase [98] . Apart from inhibitors of ETC complexes I and III, the only other class of chemicals which is known to mimic hypoxia (without changing PO 2 ) is redox agents-agents that can reduce (donate an electron) or oxidize (remove an electron). Treatment of rat PAs and aortic rings with diamide (a sulfhydryl oxidant) or oxidized glutathione (GSSG) causes relaxation of PA rings and (in parallel patch clamp experiments) opens Kv channels, as measured by increases in whole-cell I K . Conversely, anti-oxidants such as co-enzyme Q10, duroquinone, or reduced glutathione (GSH) elicit dose-dependent, endothelium-independent vasoconstriction [78] and inhibit I K in PASMCs (mimicking hypoxia) [78, 93] (Fig. 6) . Based on the concordant effects of reducing agents and ETC inhibitors in the pulmonary vasculature, it appears that states of reduction (like authentic hypoxia itself) cause pulmonary vasoconstriction, while oxidants (like normoxia itself) cause vasodilatation.
The use of comparative physiology, contrasting the pulmonary to systemic vasculature, has also been helpful in identifying the role of the mitochondrial redox O 2 sensor. Compared to isolated RA rings, PA rings have greater normoxic Fig. 3 The Redox Theory of HPV. a Illustration of a left lung experiencing regional hypoxia in the left lower lobe. Well-ventilated portions of the lung have pink blood vessels and increased blood flow (indicated by thick arrows), whereas the hypoxic region of the lung is blue with small, constricted, blue blood vessels and diminished blood flow (indicated by a thin arrow). b Inset of lung illustrating oxygenated alveoli and dilated blood vessels in a normoxic region of the lung versus hypoxic alveoli and constricted pulmonary arteries in a hypoxic region of the lung. c Inset of pulmonary artery illustrating the proximity of PASMC mitochondria to a hypoxic alveolus. d Under normoxic conditions, mitochondrial ROS production and elevated NAD(P)/NAD(P)H ratio contribute to an oxidative environment, resulting in oxidized sulfhydryl groups on K + channels, keeping them open, while the Ca L channel remains closed. e During hypoxia, diminished ROS production and reduced NAD(P)/NAD(P)H ratio result in depolarization of the cell, closing of K + channels and subsequent opening of Ca L channels. Influx of Ca 2+ triggers Ca 2+ release from the sarcoplasmic reticulum (SR), stimulating actin and myosin and triggering vasoconstriction production of H 2 O 2 and, unlike RA rings, decrease ROS production upon exposure to both hypoxia and inhibitors of the proximal ETC (e.g., rotenone or antimycin A). As a result, whereas hypoxia decreases I K in the PASMCs and causes vasoconstriction, it increases I K and elicits vasodilation in the RASMC [61] .
While there is agreement in the literature that the mitochondrion is likely the oxygen sensor responsible for producing mediator ROS, whether hypoxia lowers or elevates ROS production is a source of lingering controversy [88, 94] . The hypothesis that ROS production decreases with hypoxia is based on the notion that, with decreased O 2 , there is reduced electron flux. Since ROS are produced by the 3 % of electron flux involving uncoupled electrons, hypoxia would be predicted to decrease ROS. Conversely, the hypothesis that hypoxia increases ROS is based on the supposition that in the absence of O 2 , there is distal obstruction of the ETC and a retrograde accumulation of electrons leading to autoxidation of the chain and ROS production [18, 33, 89, 90, 92] . Interestingly, there is no disagreement that ROS increase with elevation of PO 2 in the ductus [77] , nor is there disagreement that ROS production is decreased during oxygen deprivation that accompanies cardiac ischemia [37] , as recently reviewed [43] .
Whether physiologic hypoxia increases or decreases mitochondrial ROS depends in part on whether there is input block concomitant with hypoxia. A reduction in electron influx into the ETC during hypoxia (resulting from simultaneous impairment of the Krebs cycle) would promote a decrease in ROS production (as we hypothesize). Conversely, ongoing input of electrons during hypoxia might favor increased ROS if the terminal electron receptor (O 2 ) were absent. Differences in the quality of the tissue preparation in which HPV is assessed, the use of different techniques for measuring ROS, and the use of anoxia (as opposed to hypoxia by some groups) may account for divergent results. Suggestions for overcoming these differences in experimentation have been previously published [66] . It is noteworthy that, over time, there has been some movement toward consensus, with the group that reports hypoxic increases in ROS conceding that mitochondrial ROS production is decreased with hypoxia, as measured with mitochondria-targeted RoGFP [91] . Interestingly, the main proponent of ROS increasing during hypoxia in the lung also noted that ROS increased during ischemia (prior to reperfusion) in the heart, noting, BSuperoxide generation occurs during ischemia before reperfusion from the ubisemiquinone site of the mitochondrial electron transport chain^ [14] . ROS reactive oxygen species a The distal ETC inhibitor cyanide induces increased cytosolic Ca2+ via a mechanism discrete of that elicited by hypoxia Fig. 4 Simultaneous measurement of ROS production via chemiluminescence and mean pulmonary artery pressure (PAP) during hypoxia in isolated rat lung. Hypoxia-induced change in luminolenhanced chemiluminescence begins earlier and peaks sooner than simultaneously measured change in mean pulmonary artery pressure during hypoxia ventilation. Magnitude of change in chemiluminescence is proportional to inspired O 2 content. This is a representative recording from a single lung. From [8] , reproduced with permission Interestingly, they performed their studies in isolated cardiac myocytes. We have performed similar studies of cardiac ischemia/reperfusion but did so measuring ROS in the Langendorff perfused heart model. We found, as do most groups, that the ischemic period is one of low, not high, ROS and that high ROS occurred with reperfusion [38] . Consequently, these groups, whether studying the left ventricle or the pulmonary vasculature, seem to disagree about the effect of oxygen deprivation on ROS production. One suspects that the difference relates to the severity of hypoxia (versus anoxia), the use of cells versus organs, and the duration/severity of oxygen deprivation. The distal half of the pathway proposed to mediate redox regulation of pulmonary vascular tone during normoxia (normoxic vasodilatation caused by H 2 O 2 -induced Kv channel opening) is operant in systemic arteries [71] .
The ductus arteriosus
The DA is a large conduit artery that connects the left pulmonary artery to the descending aorta. In utero, where the fetus' systemic PO 2 is <40 mmHg, the DA is maintained in a state of hypoxic vasodilatation. This ductal patency diverts placentally oxygenated blood ejected from the right ventricle away from the unventilated fetal lungs and, instead, directs it to the systemic vasculature. Upon birth, as the infant breathes oxygen-rich air, the FiO 2 rises and systemic PO 2 increases, Similarities between Sprague-Dawley rats exposed to chronic hypoxia and the fawn hooded rat that exhibits spontaneous PAH. Early loss of ROS precedes spontaneous PAH in FHR. a Lung histology reveals that 40-week-old FHRs have increased medial hypertrophy of small pulmonary arteries versus 40-week-old Sprague-Dawley rats (*P<0.05). b Expression of electron transport chain complexes is decreased in FHR pulmonary arteries before PAH (voltage-dependant anion channel expression is increased). FHR PASMCs express less electron transport chain complex I and have fewer mitochondria arrayed in a less organized reticulum than FHR/BN1 PASMCs. c Hypoxic and rotenone vasoconstriction and lung ROS levels (luminol) are similarly impaired in normoxic FHRs and chronically hypoxic Sprague-Dawley rats versus normoxic Sprague-Dawley rats (*P<0.05). From [15] , reproduced with permission leading to DA constriction. DA constriction is regulated by endothelial-derived vasodilator and vasoconstrictor mediators, including various prostaglandins [45, 56] and endothelin [20] . Anatomical patency of the ductus arteriosus is considered physiological during the first 3 days of life [83] , but persistence of ductal patency (PDA) subsequent to this can lead to pulmonary hypertension and congestive heart failure [34] . The prevalence of PDA is estimated to be 57 per 100,000 live births, with considerably higher incidence in preterm infants (birth weight 501-1500 g) [39] . Epidemiological findings highlight the importance of oxygen sensing in promoting PDA, including the increased incidence of PDA in infants born into environmental hypoxia at high altitude (4000+m) compared to babies born at sea level [2] .
Oxygen sensing in the DA
An early theory for oxygen-induced DA constriction is summarized in the endothelin hypothesis [19] . In this theory, a rise in PO 2 elicited increased synthesis of this potent peptide vasoconstrictor, resulting in DA constriction. Invoking a circulating vasoconstrictor mediator to explain DA constriction is similar to early theories of HPV, where the proposed a b Fig. 6 Reducing agents inhibit and oxidants enhance PASMC K + current. Effect of intracellular oxidants and reducing agents on wholecell potassium currents in rat pulmonary artery smooth muscle cells. a Family of K+ currents elicited b voltage steps before (left) and after (middle) 5-min dialysis of oxidized glutathione (GSSG) and currentvoltage relationship for mean (±SEM) potassium current in the presence or absence of 2 mM GSSG (right). b Series of K+ currents elicited by a repetitive voltage step from −70 to +70 mV, every 20 s after start of dialysis of reduced glutathione (GSH) (left) and current-voltage relationship for mean (±SEM) potassium current in the presence or absence of 2 mM GSH (right). Graphical representation of currentvoltage relationships for mean (±SEM) potassium current in the presence or absence of c 100 μM co-enzyme Q 10 , d 100 μM duroquinone, and e 100 μM diamide. Panels (a) and (b) from [93] , panels (c)-(e) from [78] , reproduced with permission mechanism involved oxygen-sensitive release of vasoconstrictive circulating mediators, such as endothelin [23, 46] or leukotrienes [54] . However, like HPV, the core of oxygeninduced DA constriction is intrinsic to the vasculature and requires neither the endothelium nor endothelin itself to occur. Like HPV, O 2 -induced DA constriction is mediated by a mitochondrial O 2 sensor within the SMC that regulates K + and Ca 2+ channels, as well as rho kinase, to initiate and sustain DA constriction, respectively.
In 1996, Tristani-Firouzi et al., using fetal rabbits and employing a similar strategy to Post et al. in studies of HPV [74] , demonstrated that the Kv channel inhibitor 4-AP induced DA constriction and that O 2 caused little additional constriction, suggesting a Kv-channel-dependent mechanism of constriction [87] . They showed that the O 2 -sensitive I K in DASMCs is a Kv current, which, when inhibited, causes membrane depolarization and activation of the Ca L channel, thereby elevating intracellular calcium and causing vasoconstriction. Roughly two thirds of the net rise in DASMC [Ca 2+ ] i originated from the extracellular compartment and entered the DASMCs via the Ca L channel. O 2 elicits constriction of the DA even in absence of endothelium [25] , suggesting that, similar to the PAs, the O 2 -sensing mechanism is intrinsic to the SMC. Indeed, in human DA rings, simultaneous inhibition of prostaglandin synthase, endothelin receptors, endothelin-converting enzyme, and nitric oxide synthase failed to attenuate O 2 -inudced DA constriction. However, this cocktail did inhibit constriction to exogenous endothelin and lowered endothelin synthesis by the ductus. Targeted inhibition of L-type Ca 2+ channels in human DA blocks normoxic constriction of the vessel [62] . Preterm DA rings exhibit reduced O 2 -mediated constriction and, as would be predicted, manifest reduced O 2 -sensitive I K density. Thus, the preterm DA is an interesting model, as both the sensor and constrictor mechanisms are immature and can be targeted individually. The decrease in O 2 -sensitive I K in preterm DASMCs is associated with decreased expression of Kv1.5 and Kv2.1 (with preserved expression of the L-type Ca 2+ channel). Gene transfer of Kv1.5 or Kv2.1 channels improves O 2 -constriction in preterm rabbit DA rings. When this therapy is made more precise and targeted solely to the SMC, gene transfer of Kv1.5 also enhances O 2 -mediated constriction in isolated human DA rings [85] . The mitochondrion is also the upstream O 2 sensor in the DA, and similar to resistance PAs, DASMC mitochondria alter ROS production (specifically, H 2 O 2 ) in proportion to PO 2 ( Table 1) . Quantification of DA ROS production (measured using luminol and lucigenin chemiluminescence) revealed increased ROS levels in normoxic versus hypoxic DA. This increase in ROS was inhibited by catalase, confirming that it reflected H 2 O 2 . Likewise, removal of H 2 O 2 by inclusion of catalase in the patch clamp pipette solution increased outward I K in isolated, hypoxic DASMCs, studied in the whole cell configuration. Conversely, H 2 O 2 supplementation using tert-butyl hydroperoxide decreased I K , suggesting that increased ROS levels inhibit K + channels within the DA. Additionally, oxidizing agents can initiate constriction of dilated hypoxic DA rings, and dilation of constricted normoxic rings can be triggered by anti-oxidants [77] . Regulation of K + channels by O 2 occurs in human DA in a manner opposing that seen in adult pulmonary arteries [62] . Exposure of human DA rings to chronic normoxia (ex vivo) decreases expression of Kv channels (including Kv1.5 and Kv2.1) and dampens DA sensitivity to 4-AP or O 2 -induced vasoconstriction. Adenoviral transfer of O 2 -sensitive Kv channel genes restores 4-AP and O 2 sensitivity. In a final example of the reverse response of the DA versus the PAs to changes in redox state, proximal ETC inhibitors mimic hypoxia in the DA, increasing outward I K , decreasing ROS production, and reversing O 2 -mediated vasoconstriction [63] .
Recently, we have explored how changes in mitochondrial form control mitochondrial function. Mitochondria exist in dynamic networks that are rapidly joining through a process called fusion, and dividing through a process called fission. The movement and division of mitochondria are collectively referred to as mitochondrial dynamics. Mitochondrial dynamics are regulated by a relatively small number of conserved, large GTPases that promote fission (dynamin related protein 1, Drp1) or fusion (mitofusin 1 and 2, Mfn1 and Mfn2; and optic atrophy 1, OPA1), reviewed in [3] . Hong et al. demonstrated that mitochondrial fission is required for O 2 -induced DA constriction and subsequent closure [40] . Using DA from both human infants and full-term rabbits, expression of the mitochondrial fission gene Drp1 was measured under hypoxic and normoxic conditions. Upon exposure to normoxia, both Drp1 activation and mitochondrial fission increase in term DASMCs. Fission increases mitochondrial complex I activity and ROS production [40] . Inhibition of mitochondrial fission using mdivi-1 selectively inhibits O 2 -induced ROS production and DA constriction, without altering constriction to other agonists. The changes in the structure of the mitochondrial network occurred in seconds, prior to changes in ROS production or tone, suggesting that fission is an obligatory initial step in oxygen sensing in the DA [40] .
Future directions
Numerous aspects of the oxygen sensing mechanism require further elucidation. While the opposing response of ion channels to ROS in PASMCs (constriction in response to decreased ROS) and DASMCs (constriction in response to increased ROS) is well documented, the basis for this opposing response requires further study.
Also, the relative importance of the various O 2 -sensitive K + channels remains somewhat controversial and warrants additional investigation. Certainly, mutation of TASK channels, one of the channel types implicated in oxygen sensing, is one newly recognized cause of heritable PAH [48] .
Although it is well established that the calcium driving DA and PA constriction originates in large part from the extracellular compartment and enters the cells via Ca L channels, the relative significance of oxygen-sensitive calcium release from either the SR or store-operated channels remains unclear.
Finally, the recognition that disorders of oxygen sensing can result in human diseases such as PAH and PDA offers new insight into disease pathogenesis [4, 31] . In chronic hypoxic pulmonary hypertension (a model for WHO Group 3 pulmonary hypertension in humans), the suppression of both mitochondrialderived H 2 O 2 production and expression of Kv1.5 is evident and can be ameliorated with Kv1.5 gene therapy [75] . Likewise, the preterm ductus arteriosus does not constrict well to oxygen and is deficient in the expression of Kv1.5 and other O 2 -sensitive Kv channels. Augmentation of Kv channel expression is therapeutic in models of patent preterm DA [85] . It is noted that Kv1.5 is present in numerous tissues other than the pulmonary vasculature, including atrial myocytes [26] , the ventricle [53] , pancreatic islets [49] , and the brain and spinal cord [81] . There is great variation in the electophysiologic properties of Kv1.5 among tissues. This relates to tissue-specific expression of different splice variants of Kv1.5. There is also heterogeneity in the composition of Kv1.5 channels based on variable α-subunit composition of the channel tetramer and variation in the associated channel β-subunits.
Systemic overexpression of Kv1.5 as a form of therapy would certainly elicit unwanted effects. For example, Kv1.5 over-expression has anti-apoptotic effects in the brain [100] , but pro-apoptotic effects in pancreatic beta cells [44] . Thus, site-specific manipulation of Kv1.5 is likely required for any potential therapeutic application. This approach has been used successfully in preclinical studies of diseases of the pulmonary vasculature [75] , ductus arteriosus [85] , and the heart [17] . Indeed, downregulation of Kv1.5 is a hallmark of PAH, seen in the PASMCs in all animal models of PAH, as well as human PAH.
Targeting the mitochondria to reduce ROS production has been investigated as a potential therapy for numerous pathologies. MitoQ, an anti-oxidant quinone moiety cross-linked to triphenylphosphonium cation, can pass through both the plasma membrane and mitochondrial membrane, where it accumulates within the mitochondrial matrix and is adsorbed and is continually recycled by complex II of the ETC [84] . MitoQ has been tested as a potential therapy for Alzheimer's disease [55] , hypertension and associated cardiovascular disease [30] , and metabolic syndrome [60] . It should be noted, however, that increased ROS is pathological in these cases, whereas diminished ROS production is observed in chronic hypoxic pulmonary hypertension and PDA, at least by some investigators. Further investigation into targeting the mitochondria to produce physiological levels of H 2 O 2 without stimulating potentially pathological over-production might be warranted to restore oxygen sensing. As an alternative to targeting the mitochondria to alter ROS production, the proteins associated with mitochondrial dynamics, specifically Drp1, may hold therapeutic promise. Inhibiting Drp1 in preclinical studies has resulted in decreased fission and cell proliferation in human PASMCs from PAH patients as well as in rodent PASMCs [52] , suggesting that regulators of the mitochondrial network are viable therapeutic targets for diseases of impaired oxygen sensing. However, inhibition of fission promotes patency of the DA, indicating that such a therapeutic approach would be unwise in the fetus or newborn.
Conclusions
The ability of specialized tissues to sense changes in oxygen and initiate homeostatic responses that optimize oxygen uptake and delivery is integral to normal development and environmental adaptation. In all tissues within the HOSS, a redox O 2 sensor (likely within the mitochondrion) alters production of diffusible mediators (including ROS, such as H 2 O 2 ). This redox signal alters the function of downstream effector ion channels (i.e., voltage-gated K + and Ca 2+ channels) and enzymes (e.g., rho kinase), which mediates vascular tone in the PAs and DA. The clinical significance of oxygen sensing is threefold: physiological, as the optimization of oxygen uptake is crucial to both development in utero as well as adaptation to changing environmental oxygen tension; medical, as HPV can be exploited in patients undergoing single-lung anesthesia to maintain systemic oxygenation [68] ; and pathological, as subversion of the oxygen-sensing pathways is relevant to disease pathogenesis in conditions such as PAH and cancer. 
